Pyrexar traveled to Kuwait to address physicians at the Kuwait Cancer Control Center (KCCC). Founded in 1968, the KCCC is affiliated with the Kuwait Ministry of Health and is dedicated to providing Cancer Care across the State of Kuwait. The center utilizes all available resources to serve cancer patients with a wide selection of treatment modalities. We hope to see hyperthermia as a featured treatment option this year.
Ahmed El Ghamry, Business Unit Manager, MedVision | Mark Falkowski, CEO - Pyrexar Medical | Ali Rabie, Senior Product Specialist, MedVision at the GUG Exhibit
International Conference on Genitourinary & Gynecological Cancers - Kuwait Conference April 14-16
Salwa Sabah Al-Ahmad presentation hall at the Marina Hotel
Salwa Sabah Al-Ahmad Theater & Hall in Kuwait City
While there, we joined our Middle East distribution partner Medvision at their booth at the GUG-KC (Genitourinary & Gynecological Cancers Kuwait Conference) held at the Salwa Sabah Al-Ahmad Theatre. The booth was visited by Dr. Mustafa Redah, Co-Minister of Health; Dr. Kholoud Al Ali, head of the KCCC; and Dr. Al Saleh, head of Radiation Oncology at KCCC. The group was very impressed by the new technologies Pyrexar has pioneered and the benefits of hyperthermia in the treatment of cancer.
A special thanks to the Medvision team for their generous hospitality during the event.